electronRx Limited
electronRx is a deep tech company based in Cambridge, UK, leading the development of novel chronic disease and hospital patient management solutions that pave the way for personalised digital medicine.
electronRx is a deep tech company formed in Cambridge, UK, to bring together
world-leading experts from interdisciplinary fields to apply a unique approach to tackling healthcare’s biggest challenges.
We are a team of 20 with diverse backgrounds in biomedical engineering, data science, machine learning, computer engineering, mathematics, physics, neuroscience, drug discovery, product
development, and more, building the interface between technology, the human body and healthcare organisations that will transform how we deliver healthcare and treat disease.
Our wide-ranging expertise allows us to work closely with clinical thought leaders on the frontlines of technological discovery in healthcare to develop novel ways to unlock previously inaccessible health insights and enable the industry-wide shift to value-based care.
The answer to reducing overcrowding in Emergency Departments and the 8am race for a GP appointment lies with the patient. We see all too often patients in a state of heightened anxiety, visiting the Emergency Department to then be released without further intervention in a matter of hours. Why? It is because they do not understand how to manage their condition. Asthma is a costly example of this. Many of the thousands of admissions to the ED every month are completely unnecessary, with many patients being released with no more intervention than the reassurance of the nurse or consultant. electronRx has been working to create a technology that gives the patient the required understanding of their condition, providing them with the ability to monitor essential bio-signs -much like diabetic patients can monitor their blood sugar - allowing them to manage their condition with correctly administered interventions, such as the use of an inhaler
Products and services
Scalable chronic disease management & prevention
Our healthcare systems currently have no means of effectively delivering the long-term, frequent monitoring needed to manage chronic disease.
Blueprint (incl. FoneDx API) is scaling the measurement of medical-grade cardiovascular and pulmonary health metrics using just smartphone sensors in an effort to transform our understanding of high-quality chronic care and alleviate the unsustainably high costs caused by non-compliance and readmissions. Working with leading cardiologists, we are building out hybrid cardiovascular disease
management plans consisting of a highly-engaging app and a real-time monitoring dashboard personalised to the patient and the provider in an effort to turn the tide on the leading cause of death (17.9 million people per year) globally.
Tackling crowding once & for all
Working with some of the world’s most innovative emergency medicine leaders, we are developing the ED3 platform to equip medical and administrative staff with the actionable, predictive insights and foresights they need to alleviate the throughput and output causes of ED and wider hospital crowding.
By harnessing the power of machine learning, we are tackling the overwhelming economic burden of increased lengths of stay, streamlining the patient journey and significantly improving patient safety and experience.
